Amneal Pharmaceuticals, Inc. (AMRX)

NASDAQ: AMRX · IEX Real-Time Price · USD

6.12

+0.07 (1.16%)

At close: May 1, 2024, 4:00 PM

5.98

-0.14 (-2.29%)

After-hours: May 1, 2024, 5:08 PM EDT

Amneal Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	99.11	35.23	256.74	347.12	152.82	218.78	77.92	37.55	65.11
Cash & Cash Equivalents	99.11	35.23	256.74	347.12	152.82	218.78	77.92	37.55	65.11
Cash Growth	181.34%	-86.28%	-26.04%	127.14%	-30.15%	180.77%	107.54%	-42.33%	-
Receivables	614.69	742.29	663.76	640.3	606.16	482.33	367.58	405.96	285.34
Inventory	581.38	530.74	489.39	490.65	381.07	457.22	284.04	266.16	234.97
Other Current Assets	82.69	103.57	110.22	73.47	70.16	128.32	42.4	16.45	19.2
Total Current Assets	1,378	1,412	1,520	1,552	1,210	1,287	771.93	726.11	604.6
Property, Plant & Equipment	550.14	589.36	639	604.71	609.15	544.15	486.76	407.4	318.82
Goodwill and Intangibles	1,489	1,695	1,760	1,827	1,802	2,081	71.04	74.37	79.52
Other Long-Term Assets	55.52	103.22	20.61	22.34	44.27	440.75	12.16	10.93	11.15
Total Long-Term Assets	2,095	2,388	2,420	2,454	2,456	3,066	569.96	492.7	409.49
Total Assets	3,473	3,799	3,940	4,006	3,666	4,353	1,342	1,219	1,014
Accounts Payable	546.44	547.85	534.96	613.45	507.48	532.14	222.44	64.34	69.93
Current Debt	227.62	104.64	46.04	57.47	36.95	21.72	89.48	36.99	59.69
Other Current Liabilities	72.53	100.31	96.24	5.98	5.97	0	-15.04	123.75	109.53
Total Current Liabilities	846.6	752.8	677.24	676.9	550.41	553.85	296.88	225.07	239.15
Long-Term Debt	2,523	2,740	2,830	2,887	2,729	2,670	1,395	1,160	952.63
Other Long-Term Liabilities	83.06	122.07	65.43	96.75	39.58	232.84	25.33	9.2	9.19
Total Long-Term Liabilities	2,606	2,863	2,895	2,984	2,769	2,903	1,421	1,170	961.82
Total Liabilities	3,453	3,615	3,573	3,661	3,319	3,456	1,717	1,395	1,201
Total Debt	2,751	2,845	2,876	2,945	2,766	2,691	1,485	1,197	1,012
Debt Growth	-3.33%	-1.08%	-2.34%	6.47%	2.77%	81.27%	23.99%	18.29%	-
Retained Earnings	-490.18	-406.18	-276.2	-286.82	-377.88	-20.92	-382.79	-175.17	-181.97
Comprehensive Income	-32.35	9.94	-24.83	-41.32	-0.07	-7.76	-14.23	-12.8	-15.84
Shareholders' Equity	19.78	298.42	360.34	303.27	232.01	504.75	-385.74	-185.29	-195.14
Net Cash / Debt	-2,651.42	-2,809.91	-2,619.32	-2,597.8	-2,613.25	-2,472.62	-1,406.82	-1,159.93	-947.21
Net Cash Per Share	-15.05	-18.62	-17.25	-17.45	-19.78	-19.43	-	-	-
Working Capital	531.27	659.02	842.87	874.64	659.8	732.79	475.05	501.04	365.45
Book Value Per Share	0.11	1.98	2.42	2.06	1.76	3.97	-1.29	-0.62	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).